Popular diabetes drug may raise risk of vision loss
A new study from the University of Toronto has raised concerns about a well-known diabetes and weight-loss drug. Researchers found that older adults with diabetes who took semaglutide—a medicine sold under the brand names Ozempic and Wegovy—had more than twice the risk of developing a serious eye condition called neovascular age-related macular degeneration (nAMD). nAMD […]
The post Popular diabetes drug may raise risk of vision loss appeared first on Knowridge Science Report.